| Earnings (Loss) Per Share Data |
The following is a reconciliation of the basic and diluted earnings per share (“EPS”) computations for both the numerator and denominator (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | 2015: | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | Basic EPS | | | | | | | | | | | | | Income from continuing operations | | $ | 33,970 |
| | | | $ | 0.35 |
| | $ | 111,359 |
| | | | $ | 1.15 |
| Loss from discontinued operations | | — |
| | | | — |
| | — |
| | | | — |
| Net income | | $ | 33,970 |
| | 96,255 |
| | $ | 0.35 |
| | $ | 111,359 |
| | 96,487 |
| | $ | 1.15 |
| Effect of Dilutive Securities | | |
| | |
| | |
| | |
| | |
| | |
| Convertible securities | | 66 |
| | 8,356 |
| | |
| | 132 |
| | 7,192 |
| | |
| Stock options, units and awards | | — |
| | 601 |
| | |
| | — |
| | 524 |
| | |
| Diluted EPS | | |
| | |
| | |
| | |
| | |
| | |
| Income from continuing operations plus assumed conversions | | $ | 34,036 |
| | | | $ | 0.32 |
| | $ | 111,491 |
| | | | $ | 1.07 |
| Loss from discontinued operations | | — |
| | | | — |
| | — |
| | | | — |
| Net income plus assumed conversions | | $ | 34,036 |
| | 105,212 |
| | $ | 0.32 |
| | $ | 111,491 |
| | 104,203 |
| | $ | 1.07 |
| | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | 2014: | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | | Income (Numerator) | | Common Shares(Denominator) | | Per Common
Share Amounts | Basic EPS | | |
| | |
| | |
| | | | | | | Income from continuing operations | | $ | 61,246 |
| | | | $ | 0.63 |
| | $ | 124,884 |
| | | | $ | 1.28 |
| Loss from discontinued operations | | (39,275 | ) | | | | (0.40 | ) | | (39,139 | ) | | | | (0.40 | ) | Net income | | $ | 21,971 |
| | 96,999 |
| | $ | 0.23 |
| | $ | 85,745 |
| | 97,777 |
| | $ | 0.88 |
| Effect of Dilutive Securities | | |
| | |
| | |
| | | | | | | Convertible securities | | 66 |
| | 8,440 |
| | |
| | 132 |
| | 8,452 |
| | | Stock options, warrants, units and awards | | — |
| | 615 |
| | |
| | — |
| | 677 |
| | | Diluted EPS | | |
| | |
| | |
| | | | | | | Income from continuing operations plus assumed conversions | | $ | 61,312 |
| | | | $ | 0.58 |
| | $ | 125,016 |
| | | | $ | 1.17 |
| Loss from discontinued operations | | (39,275 | ) | | | | (0.37 | ) | | (39,139 | ) | | | | (0.37 | ) | Net income plus assumed conversions | | $ | 22,037 |
| | 106,054 |
| | $ | 0.21 |
| | $ | 85,877 |
| | 106,906 |
| | $ | 0.80 |
|
EPS is reported independently for each amount presented. Accordingly, the sum of the individual amounts may not necessarily equal the separately calculated amounts for the corresponding period.
The Company is required to include additional shares in its diluted shares outstanding calculation based on the treasury stock method when the average market price of a share of Omnicare common stock on the New York Stock Exchange for the applicable period exceeds the following amounts:
| | | | Convertible Debt | | Price | 3.75% convertible senior subordinated notes, due 2025 | | $26.56 | 4.00% junior subordinated convertible debentures, due 2033 | | $40.82 | 3.25% convertible senior debentures, due 2035 | | $77.00 | 3.25% convertible senior exchange debentures, due 2035 | | $77.00 | 3.50% convertible senior subordinated notes, due 2044 | | $70.00 |
Diluted weighted average shares outstanding for the three and six months ended June 30, 2015 and 2014 excludes the impact of an immaterial number of stock options and stock awards with exercise prices that are greater than the average fair market value of the Company’s common stock during the applicable period. |